Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
D
086450
vs
K
KOSPI 200
Over the past 12 months, Dongkook Pharmaceutical Co Ltd has underperformed KOSPI 200, delivering a return of +36% compared to KOSPI 200's +65% growth.
Stocks Performance
086450 vs KOSPI 200
Performance Gap
086450 vs KOSPI 200
Performance By Year
086450 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Dongkook Pharmaceutical Co Ltd
Glance View
Dongkook Pharmaceutical is a South Korean drug maker that develops, manufactures, and sells medicines for everyday medical needs. Its lineup includes prescription drugs and branded over-the-counter products such as pain relief patches, digestive remedies, and cold or cough medicines. In simple terms, it turns pharmaceutical ingredients into finished medicines that patients can buy through doctors, hospitals, clinics, pharmacies, and drug wholesalers. The company makes money mainly by selling its own products through medical and retail pharmacy channels. It also earns revenue from supplying medicines to healthcare institutions and distribution partners. Because it owns the product brands and the manufacturing process, it sits in the middle of the value chain rather than acting only as a distributor. What makes its business model different is the mix of consumer health products and more formal prescription medicines. That gives it exposure to both pharmacy shelves and physician-prescribed treatment, which can create steadier demand than relying on just one channel. For beginner investors, think of Dongkook as a domestic pharmaceutical producer with a broad portfolio of medicines sold under its own names.